Research Area / Fields

  1. Antitumor effects of cannabinoids on cancer, inflammatory diseases and disorders of the nervous system (Epilepsy, Alzheimer, sleep disorders and more).
  2. Pharmaceutical effects of psychedelic mushrooms and Agae on cancer, inflammatory diseases and disorders of the nervous system.

Short Bio

Assistant Professor David (Dedi) Meiri comes from a highly diverse background. He holds an M.Sc. in biochemistry and a Ph.D. in plant biotechnology from Tel Aviv University. He conducted his postdoctoral fellowship at the Ontario Cancer Institute, where he focused on the role of the GEF-H1 protein in tumor invasion and metastasis, receiving in a short time worldwide recognition as an expert in the fields of G-protein coupled receptors and small GTPases. Upon completion of his postdoctoral fellowship, Dr Meiri took a position at the Technion – Israel Institute of Technology, where he heads the “Laboratory of Cancer Biology and Cannabinoid Research” and a member of the Technion Integrated Cancer center.

Available Technologies for commercialization

arrow Business Development Contacts
Motti Koren
Director of Business Development, Life Sciences